quinoxalines has been researched along with Chagas Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognesi, ML; Encalada, R; Espinoza-Hicks, JC; Gớmez-Escobedo, R; González-González, A; Krauth-Siegel, RL; Nogueda-Torres, B; Paz-González, AD; Rivera, G; Saavedra, E; Sánchez-Sánchez, O; Vázquez-Jiménez, LK | 1 |
| Ospina-Villa, JD; Soto-Sánchez, J | 1 |
| Lopez-Cedillo, JC; Moo-Puc, R; Nogueda-Torres, B; Patel, JN; Patel, NB; Patel, VM; Purohit, AC; Rajani, DP; Rivera, G | 1 |
| Aldana, I; Arbillaga, L; Azqueta, A; Birriel, E; Cerecetto, H; Crawford, PW; Devarapally, G; Di Maio, R; Galiano, S; González, M; Monge, A; Moreno-Viguri, E; Pérez-Silanes, S; Torres, E; Varela, J | 1 |
| Aguilera-Venegas, B; Arán, VJ; Kemmerling, U; Lapier, M; López-Muñoz, R; Maya, JD; Mendizábal, F; Norambuena, E; Olea-Azar, C | 1 |
1 review(s) available for quinoxalines and Chagas Disease
| Article | Year |
|---|---|
Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
Topics: Animals; Antiparasitic Agents; Benzene; Chagas Disease; Humans; Leishmaniasis; Malaria; Oxidation-Reduction; Oxides; Pyrazines; Quinoxalines; Structure-Activity Relationship | 2021 |
4 other study(ies) available for quinoxalines and Chagas Disease
| Article | Year |
|---|---|
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-
Topics: Chagas Disease; Enzyme Inhibitors; Humans; NADH, NADPH Oxidoreductases; Oxides; Quinoxalines; Trypanocidal Agents; Trypanosoma cruzi | 2022 |
In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents.
Topics: Animals; Anti-Infective Agents; Bacteria; Chagas Disease; Disease Models, Animal; Fungi; Male; Mice; Molecular Structure; Oxadiazoles; Quinoxalines; Trypanosoma cruzi | 2017 |
Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
Topics: Animals; Antiprotozoal Agents; Cell Line; Chagas Disease; Electrochemistry; Mice; Mutagenesis; Oxides; Quinoxalines; Trypanosoma cruzi | 2013 |
ESR, electrochemical, molecular modeling and biological evaluation of 4-substituted and 1,4-disubstituted 7-nitroquinoxalin-2-ones as potential anti-Trypanosoma cruzi agents.
Topics: Animals; Cell Line; Chagas Disease; Electrochemistry; Electron Spin Resonance Spectroscopy; Humans; Models, Chemical; Molecular Structure; NADH, NADPH Oxidoreductases; Nitrogen Compounds; Oxidation-Reduction; Quinoxalines; Trypanocidal Agents; Trypanosoma cruzi | 2011 |